Researchers map rare cancer gene to guide future treatments
NCT ID NCT04010240
Summary
This study aimed to understand how often a specific genetic change called an NTRK fusion occurs in people with advanced solid tumors. Researchers analyzed tumor samples from over 3,800 patients who had already received cancer treatment. The goal was to gather information to help doctors better identify which patients might benefit from new, targeted therapies for these genetic changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonié
Bordeaux, Aquitaine, 33000, France
Conditions
Explore the condition pages connected to this study.